Bank Of America Corp Phio Pharmaceuticals Corp. Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.73 - $1.1 $11 - $17
-16 Closed
0 $0
Q4 2021

Feb 08, 2022
SELL
$0.99 - $1.99 $46 - $93
-47 Reduced 74.6%
16 $0
Q3 2021

Nov 15, 2021
BUY
$1.62 - $2.28 $102 - $143
63 New
63 $0

Others Institutions Holding PHIO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Phio Pharmaceuticals Corp.

PHIO Quotes by TradingView
  • Ticker PHIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,658,700
  • Market Cap $30M
  • Description
  • Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...
More about PHIO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email